Brienne E. Engel

591 total citations
9 papers, 388 citations indexed

About

Brienne E. Engel is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brienne E. Engel has authored 9 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brienne E. Engel's work include Lung Cancer Treatments and Mutations (4 papers), Cancer-related Molecular Pathways (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Brienne E. Engel is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer-related Molecular Pathways (3 papers) and Inflammatory mediators and NSAID effects (2 papers). Brienne E. Engel collaborates with scholars based in United States, Puerto Rico and Spain. Brienne E. Engel's co-authors include W. Douglas Cress, Eric B. Haura, Matthew B. Schabath, Amer A. Beg, S. Antonia, Jhanelle E. Gray, Lieping Chen, Min Xie, William J. Fulp and Zachary Thompson and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

Brienne E. Engel

9 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brienne E. Engel United States 6 223 207 158 137 49 9 388
S. Antonia United States 8 196 0.9× 233 1.1× 223 1.4× 115 0.8× 36 0.7× 22 426
Judit Matito Spain 9 218 1.0× 97 0.5× 208 1.3× 72 0.5× 63 1.3× 23 365
Mohamed Kabbout United States 9 242 1.1× 128 0.6× 82 0.5× 126 0.9× 22 0.4× 11 353
Esther Sanfeliu Spain 5 149 0.7× 157 0.8× 131 0.8× 106 0.8× 35 0.7× 24 338
Nadia Tosti Switzerland 10 162 0.7× 66 0.3× 135 0.9× 166 1.2× 42 0.9× 16 328
Nobuhiko Nishijima Japan 8 133 0.6× 143 0.7× 110 0.7× 79 0.6× 20 0.4× 15 302
Yuichi Ishikawa Japan 5 208 0.9× 86 0.4× 102 0.6× 133 1.0× 20 0.4× 8 329
Helle Kristensen Denmark 9 280 1.3× 143 0.7× 71 0.4× 256 1.9× 39 0.8× 12 417
Guohua Rong China 11 109 0.5× 65 0.3× 157 1.0× 114 0.8× 28 0.6× 13 265

Countries citing papers authored by Brienne E. Engel

Since Specialization
Citations

This map shows the geographic impact of Brienne E. Engel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brienne E. Engel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brienne E. Engel more than expected).

Fields of papers citing papers by Brienne E. Engel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brienne E. Engel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brienne E. Engel. The network helps show where Brienne E. Engel may publish in the future.

Co-authorship network of co-authors of Brienne E. Engel

This figure shows the co-authorship network connecting the top 25 collaborators of Brienne E. Engel. A scholar is included among the top collaborators of Brienne E. Engel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brienne E. Engel. Brienne E. Engel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zajac‐Kaye, Maria, Lizi Wu, Frederic J. Kaye, et al.. (2020). Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer. UNC Libraries. 1 indexed citations
2.
Chen, Lu, Brienne E. Engel, Eric A. Welsh, et al.. (2016). A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma. Journal of Thoracic Oncology. 11(6). 838–849. 24 indexed citations
3.
Chen, Lü, Eric A. Welsh, Brienne E. Engel, et al.. (2016). Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma. Oncotarget. 7(50). 82254–82265. 7 indexed citations
4.
Engel, Brienne E., et al.. (2015). The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts. PLoS ONE. 10(11). e0142406–e0142406. 4 indexed citations
5.
Schabath, Matthew B., William J. Fulp, Lieping Chen, et al.. (2015). Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. Oncogene. 35(24). 3209–3216. 271 indexed citations
6.
Cao, Chunxia, Ruli Gao, Min Zhang, et al.. (2014). Role of LKB1-CRTC1 on Glycosylated COX-2 and Response to COX-2 Inhibition in Lung Cancer. JNCI Journal of the National Cancer Institute. 107(1). 358–358. 37 indexed citations
7.
Engel, Brienne E., et al.. (2014). The retinoblastoma protein: a master tumor suppressor acts as a link between cell cycle and cell adhesion. PubMed. 7. 1–1. 25 indexed citations
8.
Engel, Brienne E., et al.. (2013). Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors. Cell Death and Disease. 4(11). e938–e938. 17 indexed citations
9.
Engel, Brienne E.. (2010). Effects of a shallow-water hydrothermal vent gradient on benthic calcifiers, Tutum Bay, Ambitle Island, Papua New Guinea. Digital Commons - University of South Florida (University of South Florida). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026